查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565079

全球器官晶片市场

Organs-on-Chips
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到2030年，全球器官晶片市场将达到5,585亿美元

2023年全球器官晶片市场估计为672亿美元，预计2030年将达到5,585亿美元，2023-2030年分析期间复合年增长率为35.3%。片上肝臟是本报告分析的细分市场之一，预计复合年增长率为 36.6%，到分析期结束时将达到 2060 亿美元。分析期间，肾臟晶片领域的复合年增长率预计为 37.4%。

美国市场预计188亿美元，中国预计复合年增长率33.4%

预计 2023 年美国器官晶片市场规模将达 188 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到799亿美元，2023-2030年分析期间复合年增长率为33.4%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 31.8% 和 29.9%。在欧洲，德国的复合年增长率预计约为 24.3%。

全球器官晶片市场 - 主要趋势与驱动因素总结

什么是器官晶片？

器官晶片是微工程设备，透过将活细胞与先进的微流体系统结合来模仿人体器官的功能和结构。这些设备通常由柔性半透明材料製成，可即时监测和分析细胞行为，使研究人员能够在高度受控的环境中研究器官功能和疾病过程。器官晶片透过模拟肺、肝、肾和心臟等特定器官的生理条件，为传统动物实验和细胞培养提供了强大的替代方案。器官晶片的潜在应用包括药物发现、疾病建模和个人化医疗。製药公司和研究机构使用这些设备来更准确地测试药物功效和毒性，减少对动物模型的依赖，并提高人体研究的精确度。随着对个人化医疗的关注，晶片器官对个别患者反应进行建模的能力进一步凸显了其改变生物医学研究领域的潜力。

科技创新如何推动器官晶片产业的发展？

由于材料科学、微流体和组织工程的创新，器官晶片市场正在经历快速成长。 3D生物列印和微加工技术的进步极大地改善了器官晶片的设计和功能，使其变得更加复杂，不仅能够复製单一器官的功能，而且能够复製不同器官之间的相互作用。这些技术进步使得能够创建互连的器官系统，也称为「晶片上的身体」模型，以更好地模拟药物和疾病在人体内的系统效应。此外，感测器和成像技术的进步正在提高即时监测细胞反应的能力，为药物和疾病过程如何在细胞层面影响人体组织提供详细的了解。研究人员也正在探索人工智慧（AI）和机器学习演算法的集成，以分析器官晶片产生的资料，以增强药物毒性和治疗结果的预测模型。这些进步正在加速将器官晶片引入学术研究和工业环境。

器官晶片最常用于哪些领域？

器官晶片广泛应用于製药业、学术研究和个人化医疗。製药公司越来越依赖这些仪器进行药物发现和临床前测试，因为它们提供了比传统方法更可靠和更具成本效益的方法来评估药物的安全性和有效性。器官晶片可以忠实地再现人体器官反应，使其成为筛检潜在候选药物和在开发过程早期识别毒性作用的理想选择。在学术和生物医学研究中，器官晶片被用作多种疾病的模型，包括癌症、心血管疾病和神经系统疾病。这些模型使研究人员能够研究疾病机制并在与人类相关的环境中测试新的治疗方法。在个人化医疗中，器官晶片正在被研究作为开发患者特异性治疗方法的工具，使用来自个别患者的细胞来创建预测治疗反应的自订器官模型。这对于癌症等疾病尤其有益，因为癌症等疾病的治疗效果因患者而异。

推动器官晶片市场成长的因素有哪些？

器官晶片市场的成长受到多种因素的推动，包括对动物测试替代品的需求不断增加、个人化医疗的兴起以及微流体和组织工程的技术进步。关键驱动因素之一是人们越来越认识到传统动物模型通常无法准确预测人类对药物和疾病的反应，从而产生了对更可靠的人体测试平台的需求。减少动物测试的监管压力以及伦理问题正在进一步推动人们对晶片器官的兴趣，因为它是一种更人道、更科学的替代方案。此外，针对个别患者客製化治疗的个人化医疗的兴起，增加了对可以预测患者特异性药物反应的客製化器官模型的需求。微加工和组织工程的进步也扩展了器官晶片的功能，使它们更加通用并适用于广泛的应用。最后，生物医学研究投资的增加以及学术机构、製药公司和政府机构之间的合作正在加速全球器官晶片的采用和商业化。

受访企业范例（共12家）

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP13775

Global Organs-on-Chips Market to Reach US$558.5 Billion by 2030

The global market for Organs-on-Chips estimated at US$67.2 Billion in the year 2023, is expected to reach US$558.5 Billion by 2030, growing at a CAGR of 35.3% over the analysis period 2023-2030. Liver-on-Chip, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth in the Kidney-on-Chip segment is estimated at 37.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.8 Billion While China is Forecast to Grow at 33.4% CAGR

The Organs-on-Chips market in the U.S. is estimated at US$18.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$79.9 Billion by the year 2030 trailing a CAGR of 33.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 31.8% and 29.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.3% CAGR.

Global Organs-on-Chips Market – Key Trends & Drivers Summarized

What Are Organs-on-Chips, and Why Are They Revolutionizing Biomedical Research?

Organs-on-chips are micro-engineered devices that mimic the functions and structures of human organs by combining living cells with advanced microfluidic systems. These devices are typically made from flexible, translucent materials that allow for real-time monitoring and analysis of cellular behavior, enabling researchers to study organ function and disease processes in a highly controlled environment. By simulating the physiological conditions of specific organs—such as the lung, liver, kidney, or heart—organs-on-chips offer a powerful alternative to traditional animal testing and cell cultures. The potential applications for organs-on-chips extend across drug discovery, disease modeling, and personalized medicine. Pharmaceutical companies and research institutions are using these devices to test drug efficacy and toxicity more accurately, reducing the reliance on animal models and increasing the precision of human-based studies. As personalized medicine gains prominence, the ability of organs-on-chips to model individual patient responses further highlights their potential to transform the field of biomedical research.

How Are Technological Innovations Advancing the Organs-on-Chips Industry?

The organs-on-chips market is experiencing rapid growth due to innovations in materials science, microfluidics, and tissue engineering. Advances in 3D bioprinting and microfabrication technologies have significantly enhanced the design and functionality of organs-on-chips, enabling the creation of more complex, multi-tissue models that can replicate not just individual organ functions, but also the interactions between different organs. These technological strides allow for the creation of interconnected organ systems, also known as "body-on-a-chip" models, which better simulate the systemic effects of drugs and diseases in the human body. Further, developments in sensor technologies and imaging techniques are improving the ability to monitor cellular responses in real time, providing detailed insights into how drugs or disease processes affect human tissue at the cellular level. Researchers are also exploring the integration of artificial intelligence (AI) and machine learning algorithms to analyze data generated from organs-on-chips, enhancing predictive models for drug toxicity and therapeutic outcomes. These advances are accelerating the adoption of organs-on-chips in both academic research and industrial settings.

Where Are Organs-on-Chips Being Used Most Prominently?

Organs-on-chips are being used extensively in the pharmaceutical industry, academic research, and personalized medicine. Pharmaceutical companies are increasingly relying on these devices for drug discovery and preclinical testing, as they offer a more reliable and cost-effective way to evaluate drug safety and efficacy than traditional methods. The ability of organs-on-chips to replicate human organ responses with high fidelity makes them ideal for screening potential drug candidates and identifying toxic effects early in the development process. In academic and biomedical research, organs-on-chips are being employed to model a wide range of diseases, including cancer, cardiovascular conditions, and neurological disorders. These models allow researchers to investigate disease mechanisms and test new treatments in a human-relevant context. In personalized medicine, organs-on-chips are being explored as a tool for developing patient-specific therapies, where cells from individual patients can be used to create custom organ models that predict how they will respond to treatments. This is especially valuable for conditions such as cancer, where treatment responses can vary significantly between patients.

What Is Driving the Growth of the Organs-on-Chips Market?

The growth in the organs-on-chips market is driven by several factors, including the increasing demand for alternatives to animal testing, the rise of personalized medicine, and technological advancements in microfluidics and tissue engineering. One of the key drivers is the growing recognition that traditional animal models often fail to accurately predict human responses to drugs and diseases, creating a demand for more reliable, human-based testing platforms. Regulatory pressure to reduce animal testing, along with ethical concerns, has further fueled interest in organs-on-chips as a more humane and scientifically robust alternative. Additionally, the rise of personalized medicine, where treatments are tailored to individual patients, is driving demand for customized organ models that can predict patient-specific drug responses. Advances in microfabrication and tissue engineering are also expanding the capabilities of organs-on-chips, making them more versatile and accessible for a broader range of applications. Finally, increasing investment in biomedical research, coupled with collaborations between academic institutions, pharmaceutical companies, and government agencies, is accelerating the adoption and commercialization of organs-on-chips across the globe.

Select Competitors (Total 12 Featured) -

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Organs-on-Chips - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Personalized Medicine and Drug Testing Spurs Growth in the Organs-on-Chips Market
    • Increasing R&D Investments in Biotechnology Strengthens Business Case for Organs-on-Chips in Drug Development
    • Advancements in Microfluidics and Tissue Engineering Propel Innovation in Organs-on-Chips Technology
    • Surge in Demand for Alternative Testing Methods Expands Market for Organs-on-Chips in Toxicity Testing
    • Rising Ethical Concerns Over Animal Testing Accelerates Adoption of Organs-on-Chips in Biomedical Research
    • Growing Application of Organs-on-Chips in Precision Medicine Expands Addressable Market for Personalized Drug Screening
    • Increasing Use of Organs-on-Chips in Disease Modeling Drives Growth in Research and Development
    • Advancements in 3D Bioprinting Technology Propel Innovation in Customizable Organs-on-Chips Platforms
    • Rising Demand for Predictive and High-Throughput Screening in Drug Discovery Fuels Adoption of Organs-on-Chips
    • Increasing Focus on Human Physiology Replication Strengthens Business Case for Organs-on-Chips in Preclinical Studies
    • Rising Use of Organs-on-Chips in Cardiovascular and Neurological Disease Studies Fuels Market Expansion
    • Increasing Application of Organs-on-Chips in Oncology and Cancer Research Propels Market Growth
    • Advancements in Integration of Sensors and Real-Time Data Analysis in Organs-on-Chips Drive Market Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Organs-on-Chips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: China 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Europe 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 46: France Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: France 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Germany 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Italy 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 58: UK Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: UK 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Rest of World 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION